Summary
Few investigations discussing an association between ABO blood groups and pancreatic cancer exist. We have selected a series of 224 patients with histologically-confirmed pancreatic cancer, and their ABO blood groups distribution was compared with two control groups: 7086 patients with various diseases (Group 1) and 7320 voluntary blood donors (Group 2). There was an increased number of pancreatic cancer among the patients with blood group B (relative risk 1.5 vs Group 1p = 0.021; 1.7 vs Group 2p = 0.0025) and a decreased number in patients with blood group O, when compared with the two control groups.
Similar content being viewed by others
References
Williamson RCN. Pancreatic cancer: the greater oncological challenge. Br. Med. J. 1988; 296: 445–446.
Aird J, Lee DR, Roberts JA. ABO blood groups and cancer of oesophagus, cancer of pancreas and pituitary adenoma. Br. Med. J. 1960; 1: 1163–1166.
Mourant AE, Kopec’ AC, Sobczak KD. Blood groups and diseases. Oxford University Press, Oxford, 1978.
Newell GR, Gordon JE, Monlezum AP, Horwitz JS. ABO blood groups and cancer. J. Natl. Cancer Inst. 1974; 52: 1425–1430.
Cubilla A, Fitzgerald PJ. Pancreas cancer. I. Duct adenocarcinoma. A clinico-pathologic study of 308 patients. Path. Ann. 1978; 13: 241–289.
Green A. The epidemiological approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiological and preventive fraction. Tissue Antigens 1982; 19: 259–268.
Rouger PH, Goossens D, Gane P, Salmon CH. Distribution of blood groups antigens in adult human pancreas. Tissue Antigen 1981; 18: 51–55.
Kim YS, Tsao D, Hicks J. McIntyre LJ. Surface membrane glycoproteins of cultured human pancreatic cancer cells. Cancer 1981; 47: 1590–1596.
Ernst C, Atkinson B, Wysocka M, Blaszczyk M, Herlyn M, Sears HF, Steplewski Z, Koprowski H. Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab. Invest. 1984; 50: 394–400.
Davidsohn IN, Ni LY, Stejskal R. Tissue isoantigens A, B and H in carcinoma of the pancreas. Cancer Res. 1971; 31: 1244–1250.
Pour PM, Uchida E, Burnett DA, Steplewski Z. Blood group antigen expression during pancreatic cancer induction in hamsters. Int. J. Pancreat. 1986; 1: 327–340.
Itzkowitz SH, Yuan M, Ferrell LD, Ratcliffe M, Chung YS, Satake K, Umeyarna K, Jones RT, Kim YS. Cancer-associated alterations of blood group antigen expression in the human pancreas. J. Natl. Cancer Inst. 1987; 79: 425–434.
Pour PM, Tempero MM, Takasaki H, Uchida E, Takiyama Y, Burnett DA. Expression of blood-group related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient’s blood group type. Canc. Res. 1988; 48: 5422–5426.
Koprowski H, Brockhaus M, Blaszczyk M, Magnani J, Steplewski Z, Ginsburg V. Lewis blood-type may affect the incidence of gastrointestinal cancer. Lancet 1982; 1: 1332–1333.
Ghadirian P, Simard A, Baillargeon J. Cancer of the pancreas in two brothers and one sister. Int. J. Pancreat. 1987; 2: 383–391.
Vogel F. ABO blood groups and disease. Am. J. Hum. Genet. 1970; 22: 464–475.
Manuila A. Blood group and disease-hard facts and delusions. JAMA 1958; 167: 2047–2053.
Wiener AS. Blood groups and disease. Am. J. Hum. Genet. 1970; 22: 476–483.
Lin RS, Kessler I. A multifactorial model for pancreatic cancer in man. Epidemiologic evidence. JAMA 1981; 245: 147–152.
Uchida E, Tempero MA, Burnett DA, Steplewski Z, Pour PM. Correlative studies on antigenicity of pancreatic cancer and blood group types. Cancer Detec. Prevent. 1987; Suppl. 1: 145–148.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Annese, V., Minervini, M., Gabbrielli, A. et al. ABO blood groups and cancer of the pancreas. Int J Pancreatol 6, 81–88 (1990). https://doi.org/10.1007/BF02933042
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02933042